Reply: Origins and Previous Applications of Causal-Benefit Models.
作者信息
Kohli-Lynch Ciaran, Thanassoulis George, Pencina Michael, Sehayek Daniel, Pencina Karol, Moran Andrew, Sniderman Allan D
机构信息
Northwestern University, Chicago, Illinois, USA.
Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, McGill University Health Centre, Montreal, Quebec.
出版信息
JACC Adv. 2024 Jul 29;3(9):101090. doi: 10.1016/j.jacadv.2024.101090. eCollection 2024 Sep.
Abstract
摘要
相似文献
1
Reply: Origins and Previous Applications of Causal-Benefit Models.回复：因果效益模型的起源与先前应用
JACC Adv. 2024 Jul 29;3(9):101090. doi: 10.1016/j.jacadv.2024.101090. eCollection 2024 Sep.
2
Origins and Previous Applications of Causal-Benefit Models.因果效益模型的起源与先前应用
JACC Adv. 2024 Jul 29;3(9):101089. doi: 10.1016/j.jacadv.2024.101089. eCollection 2024 Sep.
3
Looking back on "causal thinking in the health sciences".回顾《健康科学中的因果思维》
Annu Rev Public Health. 2000;21:101-19. doi: 10.1146/annurev.publhealth.21.1.101.
4
Hypertension of Developmental Origins: Consideration of Gut Microbiome in Animal Models.发育起源性高血压：动物模型中肠道微生物群的考量
Biomedicines. 2022 Apr 9;10(4):875. doi: 10.3390/biomedicines10040875.
5
The origins of causal perception: evidence from postdictive processing in infancy.因果认知的起源：来自婴儿期后向加工的证据。
Cogn Psychol. 2008 Nov;57(3):262-91. doi: 10.1016/j.cogpsych.2008.02.003. Epub 2008 Jun 13.
6
Infants' representations of michottean triggering events.婴儿对米肖触发事件的反应。
Cognition. 2024 Sep;250:105844. doi: 10.1016/j.cognition.2024.105844. Epub 2024 Jun 8.
7
Causal Inference in Developmental Origins of Health and Disease (DOHaD) Research.健康与疾病发育起源（DOHaD）研究中的因果推断。
Annu Rev Psychol. 2016;67:567-85. doi: 10.1146/annurev-psych-122414-033352. Epub 2015 Oct 6.
8
Evolutionary history versus current causal role in the definition of disorder: reply to McNally.疾病定义中的进化史与当前因果作用：对麦克纳利的回应
Behav Res Ther. 2001 Mar;39(3):347-66. doi: 10.1016/s0005-7967(00)00070-x.
9
Animal Models for DOHaD Research: Focus on Hypertension of Developmental Origins.发育起源性健康与疾病（DOHaD）研究的动物模型：聚焦发育起源性高血压
Biomedicines. 2021 May 31;9(6):623. doi: 10.3390/biomedicines9060623.
10
SMT and TOFT Integrable After All: A Reply to Bizzarri and Cucina.毕竟，SMT和TOFT是可整合的：对比扎里和库奇纳的回应。
Acta Biotheor. 2017 Mar;65(1):81-85. doi: 10.1007/s10441-016-9286-z. Epub 2016 Aug 17.
本文引用的文献
1
The Causal-Benefit Model to Prevent Cardiovascular Events.预防心血管事件的因果效益模型
JACC Adv. 2024 Jan 22;3(3):100825. doi: 10.1016/j.jacadv.2023.100825. eCollection 2024 Mar.
2
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南：通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
3
Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment.胆固醇不仅与心血管风险有关，对于决定哪些人应该接受他汀类药物治疗也很重要。
Eur Heart J. 2015 Nov 14;36(43):2975-83. doi: 10.1093/eurheartj/ehv340. Epub 2015 Aug 4.
4
Taking a longer term view of cardiovascular risk: the causal exposure paradigm.从更长远的角度看待心血管风险：因果暴露范式。
BMJ. 2014 May 21;348:g3047. doi: 10.1136/bmj.g3047.
5
An evidence based approach to individualising treatment.一种基于证据的个体化治疗方法。
BMJ. 1995 Nov 18;311(7016):1356-9. doi: 10.1136/bmj.311.7016.1356.
Zotero 插件